SLC2A1 and cancer: The most potent inhibitor, termed Glupin, selectively blocks glucose uptake mediated by GLUT‐1 and GLUT‐3 with low nanomolar potency, inhibits glycolysis, and efficiently suppresses the growth of various cancer cell lines.